NDAORALSOLUTION
Approved
Sep 2003
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
5
Clinical Trials (5)
A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density
Started May 2006
247 enrolled
Postmenopausal Osteoporosis
A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.
Started May 2006
1,189 enrolled
OsteoporosisOsteopenia
Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis
Started Oct 2003
22 enrolled
Osteoporosis
Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis
Started Sep 2000
10 enrolled
Osteoporosis
Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.
Started Jun 2000
140 enrolled
Healthy